| First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano … BA Pons-Estel, E Bonfa, ER Soriano, MH Cardiel, A Izcovich, F Popoff, ... Annals of the rheumatic diseases 77 (11), 1549-1557, 2018 | 153 | 2018 |
| Early proteinuria response: a valid real-life situation predictor of long-term lupus renal outcome in an ethnically diverse group with severe biopsy-proven nephritis? MR Ugolini-Lopes, LPC Seguro, MXF Castro, D Daffre, AC Lopes, ... Lupus science & medicine 4 (1), e000213, 2017 | 97 | 2017 |
| Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid … LA Aguila, MRU Lopes, FZ Pretti, PD Sampaio-Barros, ... Clinical rheumatology 33, 1093-1098, 2014 | 86 | 2014 |
| Extra-criteria manifestations of antiphospholipid syndrome: risk assessment and management M Radin, MR Ugolini-Lopes, S Sciascia, D Andrade Seminars in arthritis and rheumatism 48 (1), 117-120, 2018 | 54 | 2018 |
| Update on antiphospholipid antibody syndrome MRU Lopes, A Danowski, A Funke, J Rêgo, R Levy, DCO Andrade Revista da Associação Médica Brasileira 63, 994-999, 2017 | 46 | 2017 |
| Metformina e AMPK: um antigo fármaco e uma nova enzima no contexto da síndrome metabólica AC Santomauro Jún, MR Ugolini, AT Santomauro, RP Souto Arquivos Brasileiros de Endocrinologia & Metabologia 52, 120-125, 2008 | 43 | 2008 |
| Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases NE Aikawa, LVK Kupa, AC Medeiros-Ribeiro, CGS Saad, EFN Yuki, ... Annals of the rheumatic diseases 81 (7), 1036-1043, 2022 | 42 | 2022 |
| Enhanced type I interferon gene signature in primary antiphospholipid syndrome: association with earlier disease onset and preeclampsia MR Ugolini-Lopes, GT Torrezan, APR Gândara, EHR Olivieri, ... Autoimmunity reviews 18 (4), 393-398, 2019 | 41 | 2019 |
| Metformin and AMPK: an old drug and a new enzyme in the context of metabolic syndrome AC Santomauro Jún, MR Ugolini, AT Santomauro, RP Souto Arquivos Brasileiros de Endocrinologia & Metabologia 52, 120-125, 2008 | 27 | 2008 |
| Impact of distinct therapies on antibody response to SARS‐CoV‐2 vaccine in systemic lupus erythematosus EFN Yuki, EF Borba, SG Pasoto, LP Seguro, M Lopes, CGS Saad, ... Arthritis care & research 74 (4), 562-571, 2022 | 26 | 2022 |
| Antiphospholipid syndrome damage index (DIAPS): distinct long-term kinetic in primary antiphospholipid syndrome and antiphospholipid syndrome related to systemic lupus … AK Torricelli, MR Ugolini-Lopes, E Bonfá, D Andrade Lupus 29 (3), 256-262, 2020 | 24 | 2020 |
| Poor Prognosis of COVID‐19 Acute Respiratory Distress Syndrome in Lupus Erythematosus: Nationwide Cross‐Sectional Population Study Of 252 119 Patients IM Bertoglio, JML Valim, D Daffre, NE Aikawa, CA Silva, E Bonfá, ... ACR Open Rheumatology 3 (11), 804-811, 2021 | 23 | 2021 |
| Serum uric acid levels are associated with lupus nephritis in patients with normal renal function AL Calich, EF Borba, MR Ugolini-Lopes, LF da Rocha, E Bonfá, R Fuller Clinical rheumatology 37, 1223-1228, 2018 | 20 | 2018 |
| Short-and long-term outcome of systemic lupus erythematosus peripheral neuropathy: bimodal pattern of onset and treatment response S Fargetti, MR Ugolini-Lopes, SG Pasoto, LPC Seguro, SK Shinjo, ... JCR: Journal of Clinical Rheumatology 27 (6S), S212-S216, 2021 | 18 | 2021 |
| Difficult clinical situations in the antiphospholipid syndrome RF Rosa, MR Ugolini-Lopes, AK Zeinad-Valim, E D’Amico, D Andrade Current Rheumatology Reports 17, 1-9, 2015 | 18 | 2015 |
| Late-onset biopsy-proven lupus nephritis without other associated autoimmune diseases: severity and long-term outcome MR Ugolini-Lopes, LPS Santos, C Stagnaro, LPC Seguro, M Mosca, ... Lupus 28 (1), 123-128, 2019 | 17 | 2019 |
| Is serum uric acid a predictor of long-term renal outcome in lupus nephritis? MR Ugolini-Lopes, SS Gavinier, E Leon, VT Viana, EF Borba, E Bonfá Clinical rheumatology 38, 2777-2783, 2019 | 12 | 2019 |
| Lúpus eritematoso sistêmico EF BORBA NETO, LPC Seguro, SG Pasoto, ESDO BONFá Clínica Médica [2ed. ampl. rev.], 2016 | 11 | 2016 |
| Antiphospholipid Syndrome Alliance for Clinical Trials & International Networking (APS ACTION) Clinical Database and Repository ("" Registry"") Analysis: First and Recurrent … O Unlu, D Andrade, A Banzato, D Branch, PR Fortin, M Gerosa, RA Levy, ... Arthritis & Rheumatology, 2017 | 10 | 2017 |
| Cognitive dysfunction and serum levels of brain-derived neurotrophic factor (BDNF) in primary anti-phospholipid syndrome (PAPS) RF Rosa, MR Ugolini-Lopes, APR Gandara, MBG Vendramini, ... Rheumatology 60 (1), 179-187, 2021 | 8 | 2021 |
